MDxHealth (FRA:O6C1) Short Interest


FRA:O6C1 MDxHealth SA FRA:O6C1
47 GF Score
Price €0.06
GF Value €0.26
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is MDxHealth Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:O6C1 vs AWHL, BIOQ, XWEL: Short Interest Comparison

For the Diagnostics & Research subindustry, MDxHealth's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MDxHealth Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, MDxHealth's Short Interest distribution charts can be found below:

* The bar in red indicates where MDxHealth's Short Interest falls into.


FRA:O6C1
47GF Score
MDxHealth SA FRA:O6C1
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MDxHealth (FRA:O6C1) Overvalued in 2026?

Based on GuruFocus' analysis, MDxHealth stock appears to be undervalued. The current stock price of €0.06 is trading 76.7% below its estimated GF Value™ of €0.26. GuruFocus considers MDxHealth to be Possible Value Trap.

Key valuation signals for FRA:O6C1:

  • Short Interest:
  • GF Value™: €0.26 vs. price of €0.06 (76.7% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the FRA:O6C1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MDxHealth Business Description

Other Exchanges MDXH:USA
Address Zone Industrielle des Hauts-Sarts, Rue d’Abhooz, 31, Cap Business Center, Herstal, Liege, BEL, 4040
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
47GF Score

Get the complete analysis for FRA:O6C1

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price
€0.26
GF Value